Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Shareholders Equity (Quarterly): 222.18M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 222.18M |
| June 30, 2023 | 156.71M |
| March 31, 2023 | 175.90M |
| December 31, 2022 | 199.41M |
| September 30, 2022 | 214.28M |
| June 30, 2022 | 240.80M |
| March 31, 2022 | 263.07M |
| Date | Value |
|---|---|
| December 31, 2021 | 286.69M |
| September 30, 2021 | 305.28M |
| June 30, 2021 | 320.63M |
| March 31, 2021 | 333.40M |
| December 31, 2020 | 125.46M |
| September 30, 2020 | 38.64M |
| December 31, 2019 | 36.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
36.50M
Minimum
Dec 2019
333.40M
Maximum
Mar 2021
208.50M
Average
218.23M
Median
Shareholders Equity (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | 575.32M |
| Zai Lab Ltd | 796.12M |
| WuXi Biologics (Cayman) Inc | 5.690B |
| Axonics Inc | 627.10M |
| I-MAB | 242.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 259.03M |
| Total Liabilities (Quarterly) | 36.85M |